Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Miriam Santero"'
Autor:
Mariana Bastos Oreiro, Reyes Martín, Pilar Gomez, Nieves López Muñoz, Antonia Rodriguez, Marta Liébana, Belén Navarro, Blanca Sánchez-González, Pilar Marí, Jaime Pérez de Oteiza, Antonio Gutiérrez, Leyre Bento, Eva Domingo Doménech, María Jesús Vidal, Raquel Del Campo, Elena Pérez Ceballos, María Infante, Alicia Roldán, Daniel García Belmonte, Miriam Santero, Anna Sureda, Ramón García Sanz, on behalf of the GELTAMO Group
Publikováno v:
Cancers, Vol 13, Iss 2412, p 2412 (2021)
Cancers
Volume 13
Issue 10
Cancers
Volume 13
Issue 10
Simple Summary As the optimal strategy for early surveillance after first complete response is unclear in Hodgkin lymphoma (HL), with the aim to identify the best one, we analyzed surveillance strategies after first-line treatment in a group of 640 H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83799def3385f2f2c885c2f0e1a728c3
https://www.mdpi.com/2072-6694/13/10/2412
https://www.mdpi.com/2072-6694/13/10/2412
Autor:
Mariana Bastos-Oreiro, Antonia Rodriguez Izquierdo, Nieves López, Antonio Gutierrez, Eva Domingo Domenech, Liébana Marta, Maria Jesus Vidal Maceñido, Jaime Pérez de Oteyza, Daniel F. Garcia, Miriam Santero, Belen Navarro, Laura Llorente, Raquel Del Campo, Leyre Bento, Ramón García-Sanz, Pilar Gomez
Publikováno v:
Blood. 134:4040-4040
Introduction The best strategy for the follow-up of patients with Hodgkin Lymphoma (HL) in complete remission (CR) after the first line of treatment is not established. The NCCN guidelines recommend follow-up computed tomography scan (CT) at 6, 12 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3faa88c22360b3e8e0ed909cbc7fbc4e
https://doi.org/10.1182/blood-2019-125813
https://doi.org/10.1182/blood-2019-125813